Millennium Management »

Eupraxia Pharmaceuticals shares owned by Millennium Management

Quarter-by-quarter ownership of Eupraxia Pharmaceuticals (EPRX) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Eupraxia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eupraxia Pharmaceuticals held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eupraxia Pharmaceuticals by Millennium Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.9M 442k 6.61
2024-12-31 $31k 10k 3.13

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf Call Option (IWM)
Ishares Tr Core S&p500 Etf (IVV)
Astrazeneca Ord Put Option (AZN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation Put Option (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Micron Technology Put Option (MU)
Microsoft Corporation Call Option (MSFT)
Amazon Put Option (AMZN)
Advanced Micro Devices (AMD)
Apple (AAPL)
Meta Platforms Cl A Put Option (META)
Space Exploration Techn Corp Class A Com Stk Call Option (SPCX)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Tesla Motors Call Option (TSLA)

View all positions for Millennium Management

Top funds holding Eupraxia Pharmaceuticals

Beutel, Goodman & Company
Affinity Asset Advisors
Balyasny Asset Management
Vivo Capital
Scotia Capital
Partner Fund Management
Dr. Jeffrey R. Jay, M.D.
Jupiter Topco
Rubric Capital Management
Ikarian Capital
Woodline Partners
Point72 Asset Management
Ameriprise Financial
Redmile Group
Seven Fleet Capital Management

View all funds holding Eupraxia Pharmaceuticals